Scott Howell

Jul 26, 2017

Tenet Diagnostics has appointed Scott Howell its CMO. He was most recently executive medical director at Heritage Provider Network. He also continues to practice at Kaiser Permanente Los Angeles Medical Center in the addiction medicine department. He was previously national senior medical director and chief medical officer Network and Population Health, Optim Insight, regional CMO Northeast region of Americhoice, and national medical director of managed care for AIDS Healthcare Foundation. 

More Like This

Aug 18, 2017

Tom Maniatis

Tom Maniatis has become scientific director and CEO of the New York Genome Center. He is the Isidore S. Edelman Professor of Biochemistry and Chair of the Department of Biochemistry and Molecular Biophysics at Columbia University. He replaces Bob Darnell, who stepped down as CEO of the NYGC last year but remains a faculty member of the center. Maniatis had already served on the  board of directors and in other leadership capacities at the NYGC since its inception.

Aug 18, 2017

Kathy Hudson

Kathy Hudson has been named executive director of the People-Centered Research Foundation, a non-profit organization committed to accelerating people-driven research that is faster, more user-friendly for patients and providers, and less costly.

Hudson most recently served as deputy director for science, outreach, and policy at the National Institutes of Health, where she played a significant role in the founding and launch of the National Center for Advancing Translational Sciences. Previously, Hudson held positions at the National Human Genome Research Institute, Johns Hopkins University, the Department of Health and Human Services, and the US Congress.

Aug 16, 2017

Bob King

Bob King has been named vice president of sales at Episona, where he will oversee the commercial expansion of the company's Seed test for evaluating male factor infertility and embryo quality. Most recently, he was director of business development and strategic accounts at Good Start Genetics. Previously, he was area sales director at Natera.

Aug 16, 2017

Eric Whitaker

Eric Whitaker has become general counsel of 10x Genomics. Most recently, he was chief legal officer at cloud computing software company Nutanix. Prior to that, he was senior vice president and chief legal officer at SanDisk, and before that, he was general counsel and corporate secretary at Tesla.

Aug 15, 2017

Manohar Furtado

LexaGene has appointed Manohar Furtado to its board of directors. With over 30 years of experience in the life science industry, Furtado has worked in discovery research, clinical diagnostic testing, product development and commercialization, M&A activity, fundraising, and strategy. He currently serves as president and founder of Biology for Global Good and CSO and chief regulatory officer at Apton Biosystems. Prior to Biology for Global Good, he served as VP of R&D at Applied Biosystems.

Aug 14, 2017

Sherrie Perkins, Andrew Theurer, Edgar Braendle

Sherrie Perkins has accepted the postion of CEO of ARUP Laboratories, while Andrew Theurer has accepted the position of president at the lab. They replace Edgar Braendle who served in both positions during the past year. Braendle is leaving ARUP to pursue other opportunities and rejoin his family in New Jersey, ARUP said. Perkins was previously senior vice president of R&D at ARUP, as well as professor, vice chair, and division chief of clinical pathology. She is a tenured professor at the University of Utah School of Medicine. Theurer was senior VP and CFO at ARUP. 

Aug 08, 2017

John Rice

Meridian Bioscience has appointed John Rice as an independent director. Rice joins Meridian from CincyTech, a firm that provides advice and capital to entrepreneurs and helps research institutions commercialize technology through startups. He has served as the director of life sciences since 2014. Rice is also the founder and, since 2003, managing partner of Triathlon Medical Ventures Partners, a venture capital firm that invests equity capital in early- and expansion-stage life science companies.

Aug 07, 2017

Paul Marr

MDxHealth has appointed Paul Marr to the post of executive VP of sales for North America. Marr previously served as VP of sales, North America for Beckman Coulter, and also has worked for Hologic, Gen-Probe, Leica Biosystems, Bayer Diagnostics, and Siemens Healthcare. He joins MDxHealth, which is based in Belgium, in conjunction with the firm's expansion of its US sales force to 50 representatives.

Aug 07, 2017

Ramesh Ramakrishnan

Dovetail Genomics has appointed Ramesh Ramakrishnan as senior vice president of research and development. Before joining Dovetail, Ramakrishnan was executive vice president of R&D at Fluidigm, where he managed the development of single-cell genomic and proteomic tools, as well as bulk genomic analysis. Prior to Fluidigm, Ramakrishnan worked at Nanosphere and Motorola Life Sciences in assay and array development.

Aug 04, 2017

Evan Wittenberg

Evan Wittenberg has joined Ancestry in the new position of chief people officer. Wittenberg joins Ancestry from Box, where he was most recently senior vice president of people. Prior to Box, Wittenberg was the chief talent officer for HP; the head of global leadership development at Google; and director of the Graduate Leadership Program at The Wharton School.

Aug 04, 2017

Madhuri Hegde

Madhuri Hegde has has been elected to the ACMG Foundation for Genetic and Genomic Medicine Board of Directors, the supporting educational foundation of the American College of Medical Genetics and Genomics. Hegde joined PerkinElmer in 2016 as vice president and CSO of Global Genetics Laboratory Services. She also is an adjunct professor of human genetics at Emory University. Previously, Hegde was executive director and CSO at Emory Genetics Laboratory in Atlanta; professor of human genetics and pediatrics at Emory University; and assistant professor of human genetics and senior director at Baylor College of Medicine in Houston.

Aug 03, 2017

Marijn Dekkers

Quanterix named Marijn Dekkers to its board. He is currently a board member at General Electric and is chairman of Unilever. He was previously CEO of Bayer and of Thermo Fisher Scientific. 

Aug 02, 2017

Bill Rastetter, Jeff Huber, Ken Drazan

Grail, a company aiming to develop a blood test for early cancer detection, has named Bill Rastetter, current chair of the company's board of directors, as its new CEO. Founding CEO Jeff Huber is now vice chairman of the board of directors, and Ken Drazan has been promoted from chief business officer to president.

Aug 02, 2017

Abraham Tzou

Freenome has appointed Abraham Tzou as its VP of regulatory affairs. Tzou will be in charge of regulatory strategy for products developed by Freenome and manage submissions to the US Food and Drug Administration and oversight bodies abroad.  

Tzou joins Freenome after serving as a medical officer at the FDA's Center for Devices and Radiological Health, where he led the clinical evaluation of in vitro diagnostics for cancer screening and prognosis, genetic disorders, and companion tests. During his tenure at the agency, he received commendation for his part in a team that reviewed Exact Sciences' non-invasive, colon cancer screening test Cologuard for parallel review. 

Freenome is developing a non-invasive cancer screening technology that involves genome-wide sequencing and a computational system, called Adaptive Genomics Engine. The company is interested in pursuing Parallel Review for this technology, which if successful, would enable simultaneous FDA approval and a national coverage determination from the Centers for Medicare & Medicaid Services.

Jul 28, 2017

Cynthia Bens

Cynthia Bens will join the Personalized Medicine Coalition as vice president of public policy on August 21. Bens comes to PMC after more than a decade with the Alliance for Aging Research where she helped advocate for policies, including the 21st Century Cures Act, the Prescription Drug User Fee Act, and FDA’s Patient-Focused Drug Development initiative. Prior to that, she spent four years at the bipartisan government affairs firm the Loeffler Group and also worked as a staff assistant on Capitol Hill.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.